Key facts
- This page summarizes Molly Harper's Form 4 filing for CATALYST PHARMACEUTICALS, INC. (CPRX).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2025, 17:00.
Molly Harper - 12 Dec 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)
- Reporting relationship
- Director
- Issuer ticker
- CPRX
- Reported as of
- 12 Dec 2025
- Net transaction value
- -$506,320
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2025, 17:00:29 UTC
- Prior SEC filing
- 10 Dec 2025
- Next SEC filing
- 30 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Molly Harper
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Molly Harper filed Form 4 for CATALYST PHARMACEUTICALS, INC. (CPRX) on 16 Dec 2025.
Change
- Previous filing in this sequence was filed on 10 Dec 2025.
- Current net transaction value: -$506,320.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001871470
Primary reporting owner
Harper Molly
- Relationship
- Director
- Address
- 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES
- Signature
- /s/ Molly Harper
- Signature date
- 16 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CPRX
transaction
Common stock, par value $0.001 per share
Options Exercise
- Transaction value
- $115,600
- Shares
- +20,000
- Change %
- +220%
- Price
- $5.78
- Shares after
- 29,106
- Date
- 12 Dec 2025
- Ownership
- Direct
CPRX
transaction
Common stock, par value $0.001 per share
Sale
- Transaction value
- $360,195
- Shares
- -15,527
- Change %
- -53%
- Price
- $23.20
- Shares after
- 13,579
- Date
- 12 Dec 2025
- Ownership
- Direct
- Footnotes
- F1, F2
CPRX
transaction
Common stock, par value $0.001 per share
Sale
- Transaction value
- $106,162
- Shares
- -4,473
- Change %
- -33%
- Price
- $23.73
- Shares after
- 9,106
- Date
- 12 Dec 2025
- Ownership
- Direct
- Footnotes
- F1, F3
CPRX
transaction
Common stock, par value $0.001 per share
Sale
- Transaction value
- $155,563
- Shares
- -6,746
- Change %
- -74%
- Price
- $23.06
- Shares after
- 2,360
- Date
- 12 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CPRX
transaction
Derivative
Options to purchase common stock
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 128,497
- Date
- 12 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $5.78
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.
Footnote F2
Represents a weighted average price for the shares sold. Shares were sold in a range between $22.67 and $23.67 per share.
Footnote F3
Represents a weighted average price for the shares sold. Shares were sold in a range between $23.67 and $23.82 per share.
Footnote F4
Options vested in three annual tranches beginning on June 29, 2022.